Evofem Biosciences Inc (OTCPK:EVFM)
$ 0.016 0.002 (14.29%) Market Cap: 993,000.00 Enterprise Value: 43.41 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q4 2019 Evofem Biosciences Inc Earnings Call Transcript

Mar 12, 2020 / 03:00PM GMT
Release Date Price: $7443.71 (-23.06%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Evofem Q4 and Year-end 2019 Financial Results Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker, Ms. Amy Raskopf. Please go ahead, ma'am.

Amy Raskopf
Evofem Biosciences, Inc. - Head of IR

Thank you. This is Amy Raskopf, Evofem Biosciences Head of Investor Relations. Today, we released our financial results for the fourth quarter and full year 2019. The press release and accompanying slides, which you can access through the webcast, are available on the Investor Relations section of the Evofem website.

Before I begin, I'd like to remind you that remarks on this call will contain forward-looking statements as stated on Slide 2. These forward-looking statements are made only as of today, March 12, 2020. Although the company may elect to update forward-looking statements from time to time in the future, we specifically disclaim any duty or obligation to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot